cost-of-illness

Original Contribution

Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy

10/25/2022

Michael Butzner, DrPH, MPH¹; Martin S. Maron, MD^2a; Phil Sarocco, MSc¹; Chia-Chen Teng, MS³; Eric Stanek, PharmD³; Hiangkiat Tan, BS³; Laura A. Robertson, MD^4b

Michael Butzner, DrPH, MPH1; Martin ...

Patients with obstructive hypertrophic cardiomyopathy (oHCM) and severe refractory symptoms may require invasive septal reduction therapies (SRTs), either surgical septal myectomy (SM) or transcatheter alcohol septal ablation (ASA). The main...

Patients with obstructive...

10/25/2022

Journal of Invasive Cardiology